We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Share this :
Print
Miltenyi Biotec Cd279 (Pd-1) Antibody, Anti-Human, Apc, Readye_Le
Miltenyi Biotec Cd279 (Pd-1) Antibody, Anti-Human, Apc, Readye_Lease - MLTY (Additional S&H or Hazmat Fees May Apply)
List Price
$533.50
Your Price
$533.50
HOW MUCH YOU SAVE:
0.00 %
NETA PART: | MLTY-130-122-169 |
MFG.PART: | 130-122-169 |
UNSPSC: | 12352203 |
Manufacturer: | Miltenyi Biotec |
Miltenyi Biotec Clone REAL531 is an antibody fragment derived from the full CD279 (PD-1) antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL531 recognizes the human CD279 antigen, also known as PD-1 (programmed death-1) or PD1. CD279 is a 55 kDa transmembrane protein belonging to the CD28/CTLA-4 family. It is expressed on T cells, B cells, NK cells, activated myeloid cells, and dendritic cells. CD279 is not expressed on naive T cells but induced after activation and expressed on late, differentiated T cells. The ligands PD-L1 (CD274, also known as B7-H1) and PD-L2 (CD273, also known as B7-DC) belong to the B7 immunglobulin superfamily. PD-1 and its ligands mediate inhibitory signals that regulate the balance between T cell activation, tolerance, and immunopathology. | PD-1 is used as a marker for angioimmunoblastic lymphoma. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). - MLTY (Additional S&H or Hazmat Fees May Apply)
SKU | MLTY-130-122-169 |
---|---|
Supplier Part Number | 130-122-169 |
UM | EA |
UNSPSC | 12352203 |
Manufacturer | Miltenyi Biotec |
MSDS URL | https://www.miltenyibiotec.com/ds/130-122-169 |
ProductLine | MLTY |
Qty | 1 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 5 Business Days |
Hazardous | N |